MEDRESPONSE CORP.

EDGAR

14 filing records in this dataset, filed from 2014-02-26 to 2017-09-25. Reported financial figures are available; chart coverage varies by period.

Watchlist

Latest quarter

Revenue

0 USD

2015 Q2 · USD

Exact inputs and evidence

Operating cash flow

-8.23 thousand USD

2015 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -8689 USD Source
  • Operating Cash Flow: -456 USD Source
Cash and cash equivalents
778 USD Source
Exact value

778 USD

Long-term debt including current maturities
Not available
Shares outstanding
9.56 million shares Source
Exact value

9560000 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 9560000 shares · 2016-06-30· Source
  • 9560000 shares · 2017-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-5.29 thousand USD

2016-07-01 – 2017-06-30

Exact inputs and evidence
  • Net income: -3684 USD · 2016-07-01 – 2016-09-30 Source
  • Net income: -10633 USD · 2016-01-01 – 2016-12-31 Source
  • Net income: -12715 USD · 2016-01-01 – 2016-09-30 Source
  • Net income: -3342 USD · 2017-01-01 – 2017-03-31 Source
  • Net income: -342 USD · 2017-04-01 – 2017-06-30 Source

Operating cash flow

-12.7 thousand USD

2016-07-01 – 2017-06-30

Exact inputs and evidence
  • Operating cash flow: -571 USD · 2016-01-01 – 2016-09-30 Source
  • Operating cash flow: -168 USD · 2016-01-01 – 2016-06-30 Source
  • Operating cash flow: -7702 USD · 2016-01-01 – 2016-12-31 Source
  • Operating cash flow: -571 USD · 2016-01-01 – 2016-09-30 Source
  • Operating cash flow: -4042 USD · 2017-01-01 – 2017-03-31 Source
  • Operating cash flow: -5189 USD · 2017-01-01 – 2017-06-30 Source
  • Operating cash flow: -4042 USD · 2017-01-01 – 2017-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-09-25.

Financial data available through: 2016-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 3 of 11 periods available· newest 2016-12-31
  • Net income: 3 of 11 periods available· newest 2016-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2016-12-31
  • Capital expenditure: 1 of 11 periods available· newest 2014-12-31
  • Total assets: 3 of 11 periods available· newest 2016-12-31
  • Total liabilities: 3 of 11 periods available· newest 2016-12-31
  • Current assets: 3 of 11 periods available· newest 2016-12-31
  • Current liabilities: 3 of 11 periods available· newest 2016-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2016-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +USD 26,621

    Prior period

    −USD 37,254

    –

    Current period

    −USD 10,633

    –

    Exact inputs and evidence

    -10633 − -37254 = 26621 USD

    -37254 USD · 2015-01-01 – 2015-12-31

    Inspect prior input Prior source

    -10633 USD · 2016-01-01 – 2016-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 5,224

    Prior period

    −USD 12,926

    –

    Current period

    −USD 7,702

    –

    Exact inputs and evidence

    -7702 − -12926 = 5224 USD

    -12926 USD · 2015-01-01 – 2015-12-31

    Inspect prior input Prior source

    -7702 USD · 2016-01-01 – 2016-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2014 2014-01-01 – 2014-12-31
−USD 15,150
Exact value

Exact value: -15150 USD

2014-01-01 – 2014-12-31: -15150 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 15,116
Exact value

Exact value: -15116 USD

2014-01-01 – 2014-12-31: -15116 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 692
Exact value

Exact value: 692 USD

2014-01-01 – 2014-12-31: 692 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 15,808
Calculation and evidence

-15116 − 692 USD

Exact free cash flow: -15808 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2015 2015-01-01 – 2015-12-31
−USD 37,254
Exact value

Exact value: -37254 USD

2015-01-01 – 2015-12-31: -37254 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12,926
Exact value

Exact value: -12926 USD

2015-01-01 – 2015-12-31: -12926 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2016 2016-01-01 – 2016-12-31
−USD 10,633
Exact value

Exact value: -10633 USD

2016-01-01 – 2016-12-31: -10633 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7,702
Exact value

Exact value: -7702 USD

2016-01-01 – 2016-12-31: -7702 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

14 filings · 509 latest values · 509 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001600750, 1600750, MTCP, edgar:1600750

Also known as MEDRESPONSE CORP., Merecot Corp.